Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 155,446 | 229,652 | 120,320 | 173,712 | 57,237 |
| Marketable Securities | 454,890 | 461,848 | 459,256 | 460,883 | 168,179 |
| Receivables | 7,384 | N/A | N/A | N/A | 25,000 |
| Inventories | 1,389 | N/A | N/A | N/A | N/A |
| TOTAL | $633,086 | $703,479 | $593,408 | $642,295 | $256,426 |
| Non-Current Assets | |||||
| PPE Net | 9,567 | 6,693 | 6,333 | 5,274 | 1,595 |
| Investments And Advances | 23,556 | 2,125 | 1,510 | 1,510 | 1,510 |
| Other Non-Current Assets | 20,096 | 20,630 | 21,158 | 522 | 476 |
| TOTAL | $53,219 | $29,448 | $29,001 | $7,306 | $3,581 |
| Total Assets | $686,305 | $732,927 | $622,409 | $649,601 | $260,007 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,582 | 11,337 | 19,575 | 14,770 | 13,900 |
| Accrued Expenses | 37,333 | 32,234 | 38,716 | 26,884 | 20,935 |
| TOTAL | $51,339 | $45,072 | $60,038 | $42,256 | $35,335 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 967 | 1,014 |
| Other Non-Current Liabilities | 15,282 | 15,595 | 15,904 | 825 | 780 |
| TOTAL | $15,282 | $15,595 | $15,904 | $1,792 | $1,794 |
| Total Liabilities | $66,621 | $60,667 | $75,942 | $44,048 | $37,129 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,377 | 55,859 | 55,645 | 51,044 | 38,215 |
| Common Shares | 561 | 557 | 516 | 510 | 382 |
| Retained earnings | -628,027 | -560,786 | -487,979 | -420,763 | -364,567 |
| Other shareholders' equity | -8 | 763 | 111 | 61 | 175 |
| TOTAL | $619,684 | $672,260 | $546,467 | $605,553 | $222,878 |
| Total Liabilities And Equity | $686,305 | $732,927 | $622,409 | $649,601 | $260,007 |